BMY Bristol-Myers Squibb Co. Net Assets per Single Share

Graphic logo of bms.com (BMY)

Manufacturing automation and AI-driven molecule discovery ensure high efficiency for Bristol-Myers Squibb (BMY), as evidenced by the calculated book value per share, which stands at 10.99. Asset growth is driven by robust R&D in immunology and oncology. Business stability is maintained through a strategy of acquiring promising biotech startups to strengthen the new drug portfolio.

BMY (Bristol Myers Squibb Company) Accounting Value of a Share history from 07/04/2022 to 10/29/2026

Analytical breakdowns for bms.com (BMY)

- share price and expert price forecast:
Stock Quotes BMS|BMY - Average Forecast Price
- market capitalization data:
Market Value Bristol-Myers Squibb|BMY - Full Business Value
- shareholders' equity book value data:
Book Value per Share Bristol Myers Squibb|BMY - Accounting Value of Company|Market Capitalization to Book Value Ratio bms.com|BMY - Company Total Assets
- debt and solvency information:
Debt to Equity Bristol-Myers Squibb|BMY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Bristol Myers Squibb|BMY - Company Total Debt|Debts to Book Capitalization Bristol-Myers Squibb|BMY - Company Long-Term Debts|Company Current Liabilities Bristol Myers Squibb|Quick Ratio bms.com
- net income and valuation multiples indicators:
BMY - Final Profit
Initial company analysis:BMS (BMY)
Mass-produced product of Bristol Myers Squibb

A high level of tangible assets provides Bristol-Myers Squibb (BMY) with resilience against volatility during drug generation shifts. While the company replaces stagnating patents with new oncology therapies, its capitalization relies on real property. The absolute book value per share, which has reached 10.99, reflects the portion of net assets per security. This basis links the market price to accounting reality. Investors should compare this coverage with the return on equity to assess business efficiency.

Competitors of Bristol-Myers Squibb (BMY)

LLY: Accounting Value per Share|Net Asset Value per Share AbbVie Corp.|AstraZeneca PLC (AZN) - Net Assets per Single Share|Share Book Value NVS (novartis.com)|MRK (Merck) - Book Value per Share|NVO: Accounting Value of a Share|Book Value per Share AMGN|Book Value per Share Pfizer Corp (PFE)|Net Assets per Single Share Sanofi SNY|Accounting Value of a Share GSK|TAK - Net Assets per Single Share|tevapharm.com (TEVA) - Accounting Value per Share|RDY: Book Value per Share|Mylan (VTRS) - Book Value per Share|Accounting Value per Share ROIV|ZLAB: Accounting Value of a Share|Book Value per Share BHC|COSM (Cosmos Health, Inc.) - Accounting Value of a Share